Mediso USA distributes the preclinical imaging portfolio of Mediso, most importantly the nanoScan Family for molecular imaging.
Members of the nanoScan Family combine the industry’s highest performing microscopy level of molecular PET and SPECT imaging supported by excellent MRI and CT performance. Mediso has designed a platform that can satisfy the increasing needs of any research institute with shared components and flexible upgrade possibilities. The ultimate versatility and in-line combinations of the preclinical imaging systems are based on shared hardware and software building blocks, common animal handling platform and easy on-site upgrade possibility, thus fulfill all demands of your growing and long term research requirements. Seven systems avaliable: standalone PET, standalone SPECT, standalone CT, bi-modal PET/CT, bi-modal SPECT/CT, bi-modal PET/MRI, bi-modal SPECT/MRI and tri-modality SPECT/CT/PET.
Mediso works in the field of design and manufacturing of high-end clinical and life science research multi-modality in vivo imaging systems. The company was founded in 1990 by experts in the largest research and manufacturing company in Europe which has been engaged in nuclear equipment development and production since 1960. The company offers complete solutions from hardware design to evaluation and quantification software both for clinical patient care and high-level life science research.